Right to Try Act modified for individualized investigational treatments.

This bill modifies Minnesota's Right to Try Act to allow patients with life-threatening or severely debilitating conditions to access individualized investigational treatments, such as gene therapies or neoantigen vaccines, that are tailored to their specific genetic profiles. It requires physicians to document that patients have explored all FDA-approved treatment options and have received a recommendation for the personalized therapy before providing informed consent. The legislation permits manufacturers to voluntarily offer these treatments without requiring them to make them available, allows patients to pay for manufacturing costs, and includes protections against liability for healthcare providers who follow the law's requirements.